What people with MS and care partners need to know about advancements in monitoring MS activity
Biomarkers are measurable tests such as blood tests, spinal fluid tests and MRI that can help your neurologist diagnose and manage your multiple sclerosis. Biomarkers provide objective data that can help clinicians identify MS earlier, track progression, and help determine response to treatment. As we know, MRI and spinal fluid analysis have been used for many years to aide in early and accurate diagnosis. In addition, MRI is used frequently to track response to MS disease modifying therapies.
How Does MS Impact You? MS Coalition Goes Straight to People with MS for the Answer in New Study
Loss of independence was the top concern in a survey of 1,323 people with MS conducted by the MS Coalition, a network of MS organizations including the National MS Society. Other major concerns were the financial and emotional impacts of MS. Studies such as these are critical to providing personalized solutions for people living with MS. See below for opportunities to participate in other research studies, and for help with managing MS.
Multiple Sclerosis (MS) treatments added to WHO’s Essential Medicines List for the first time
Vaccination against COVID-19 is critical for public safety and, especially, the safety of the most vulnerable among us. Get your vaccine as soon as it is available to you. If you have MS, visit nationalMSsociety.org/covid19 to learn the latest about COVID-19 vaccines and MS.
COVID-19 mRNA vaccine guidance for people living with MS
Vaccination against COVID-19 is critical for public safety and, especially, the safety of the most vulnerable among us. Get your vaccine as soon as it is available to you. If you have MS, visit nationalMSsociety.org/covid19 to learn the latest about COVID-19 vaccines and MS.
Congress Passes The Families First Coronavirus Response Act
On March 18th, the President signed the Families First Coronavirus Response Act (H.R. 6201) – a legislative package that contains important provisions that could affect people living with MS. The U.S. House of Representatives passed this legislation on March 14th and the U.S. Senate passed this legislation on March 18th. Patients with chronic health conditions […]
What You Need to Know About COVID-19 Town Hall
We are closely watching the coronavirus (COVID-19) situation and taking action as we all move through this uncharted territory. The National MS Society and the Consortium of MS Centers hosted a virtual What You Need to Know About COVID-19 town hall meeting for healthcare providers with Aaron Miller, MD, Medical Director at the Corinne Goldsmith […]
Guidance for the use of disease modifying therapies during the COVID-19 pandemic
Guidance for the use of disease modifying therapies during the COVID-19 pandemic People with MS have asked for guidance on the use of Disease Modifying Therapies (DMTs) during the COVID-19 pandemic. There are numerous recommendations circulating that attempt to provide clarity and guidance, however, differences among the recommendations have created confusion. DMT decision making varies […]
